Page last updated: 2024-08-18

pyrroles and Low Bone Density

pyrroles has been researched along with Low Bone Density in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basile, G; Catalano, A; Cucinotta, D; Lasco, A; Morabito, N	1
Burnett, K; Chang, WY; Chen, Y; Griffiths, KN; Hogue, A; López, FJ; Mais, DE; Marschke, K; Meglasson, MD; Pedram, B; Shen, Y; Vajda, EG; van Oeveren, A; Zhi, L	1
Barut, A; Sarikaya, S; Tanriverdi, HA	1
Feyen, J; Glatt, M; Green, J; Jeschke, M; Missbach, M; Müller, K; Susa, M	1

Trials

2 trial(s) available for pyrroles and Low Bone Density

Article	Year
Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women. European journal of clinical investigation, 2015, Volume: 45, Issue:2 Topics: Administration, Oral; Atorvastatin; Bone Diseases, Metabolic; Calcifediol; Cholecalciferol; Dietary Supplements; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Middle Aged; Postmenopause; Pyrroles; Vitamin D; Vitamin D Deficiency; Vitamins	2015
Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. European journal of obstetrics, gynecology, and reproductive biology, 2005, May-01, Volume: 120, Issue:1 Topics: Atorvastatin; Bone Density; Bone Diseases, Metabolic; Cholesterol; Cholesterol, LDL; Drug Therapy, Combination; Etidronic Acid; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Pelvic Bones; Postmenopause; Pyrroles; Risedronic Acid	2005

Article

Year

Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women.

European journal of clinical investigation, 2015, Volume: 45, Issue:2

Topics: Administration, Oral; Atorvastatin; Bone Diseases, Metabolic; Calcifediol; Cholecalciferol; Dietary Supplements; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Middle Aged; Postmenopause; Pyrroles; Vitamin D; Vitamin D Deficiency; Vitamins

2015

Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.

European journal of obstetrics, gynecology, and reproductive biology, 2005, May-01, Volume: 120, Issue:1

Topics: Atorvastatin; Bone Density; Bone Diseases, Metabolic; Cholesterol; Cholesterol, LDL; Drug Therapy, Combination; Etidronic Acid; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Pelvic Bones; Postmenopause; Pyrroles; Risedronic Acid

2005

Other Studies

2 other study(ies) available for pyrroles and Low Bone Density

Article	Year
Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2009, Volume: 24, Issue:2 Topics: Absorptiometry, Photon; Androgen Antagonists; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Drug Synergism; Drug Therapy, Combination; Estrogens; Female; Femur; Lumbar Vertebrae; Male; Orchiectomy; Organ Size; Osteocalcin; Ovariectomy; Pyrroles; Quinolones; Rats; Rats, Sprague-Dawley; Transcription, Genetic	2009
A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone, 1999, Volume: 24, Issue:5 Topics: 3T3 Cells; Animals; Bone Diseases, Metabolic; Bone Resorption; Cell Adhesion Molecules; Cell Survival; CSK Tyrosine-Protein Kinase; Cytoskeletal Proteins; Disease Models, Animal; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Mice; Oncogene Protein pp60(v-src); Osteoblasts; Ovariectomy; Paxillin; Phosphoproteins; Phosphorylation; Pregnancy; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; src-Family Kinases	1999

Article

Year

Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2009, Volume: 24, Issue:2

Topics: Absorptiometry, Photon; Androgen Antagonists; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Drug Synergism; Drug Therapy, Combination; Estrogens; Female; Femur; Lumbar Vertebrae; Male; Orchiectomy; Organ Size; Osteocalcin; Ovariectomy; Pyrroles; Quinolones; Rats; Rats, Sprague-Dawley; Transcription, Genetic

2009

A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo.

Bone, 1999, Volume: 24, Issue:5

Topics: 3T3 Cells; Animals; Bone Diseases, Metabolic; Bone Resorption; Cell Adhesion Molecules; Cell Survival; CSK Tyrosine-Protein Kinase; Cytoskeletal Proteins; Disease Models, Animal; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Mice; Oncogene Protein pp60(v-src); Osteoblasts; Ovariectomy; Paxillin; Phosphoproteins; Phosphorylation; Pregnancy; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; src-Family Kinases

1999